Similarly, seven out of 19 patients (36.84%) with lymph node metastases expressed E-cadherin positively, whereas 26 out of 33 patients (78.79%) without lymph node metastases showed positive expression. This evidence concerns the gene CDH1 and metastatic malignant neoplasm in the lymph nodes.